Indivior Stock Discussion

$Indivior (INDV.US)$
Game-Changing OUD Treatment Update: SUBLOCADE Now Offers 1-Hour Start Protocol

$Indivior (INDV.US)$
Unexpected FDA Delay: Indivior's SUBLOCADE Label Changes Face Setback Despite Clean Review

$Indivior (INDV.US)$
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...